The Englander Institute for Precision Medicine Seminar Series

Our monthly seminar series is a CME accredited event held on the first Tuesday of each month at 12:45pm.

Upcoming Seminars:

  • Tuesday, November 12, 2019–“EIPM Seminar Series Lecture,” with Laura Santambrogio, M.D., Ph.D., EIPM Associate Director for Precision Immunology
  • Wednesday, December 11, 2019–“EIPM Seminar Series Lecture,” with Seth Paul Lerner, M.D., FACS, Professor of Urology, Baylor College of Medicine
  • Thursday, December 12, 2019–“EIPM Seminar Series Lecture,” with Yuri E. Nikiforov, M.D., Ph.D. Professor of Pathology, University of Pittsburgh

# # #

Previous Seminars:

October 22, 2019

EIPM Seminar Series Lecture, “Clinically relevant mutational signatures in childhood cancer,” with Adam Shlein, Ph.D.

Assistant Professor, Peter Gilgan Centre for Research and Learning, Hospital for Sick Children.



October 21, 2019

EIPM Seminar Series Lecture, “Whole-genome sequencing-based diagnostics for cancer precision medicine,” with Edwin Cuppen, Ph.D.

Director Hartwig Medical Foundation, Professor of Human Genetics.


October 8, 2019

EIPM Seminar Series Lecture, “A Pan-Cancer Perspective to Cancer Classification,” with Katie Hoadley, Ph.D.

Assistant Professor, UNC


September 24, 2019

EIPM Seminar Series Lecture, “Mass Cytometry at WCM,” with Hiranmayi Ravichandran.

EIPM Mass Cytometry Specialist to discuss Imaging Mass Cytometry and Cells in Suspension




September 23, 2019

“The 100,000 Genomes Project: New Genes for Rare Blood Diseases,” by Willem H Ouwehand FMedSci.

Professor of Experimental Haematology, University of Cambridge and Wellcome Sanger Institute & NHS Blood and Transplant.



September 17, 2019

“Using Stem Cells to Model Healthy and Cancerous Kidney Tissue,” with Leif Oxburgh, DVM, Ph.D.

Senior Scientist, Maine Medical Center Research Institute, Professor, Tufts University School of Medicine.


“Monitoring Clonal Dynamics of Cancer in the Clinic”
Presented by:
Shridar Ganesan, M.D., Ph.D.Chief, Molecular Oncology
Associate Director for Translational Research, Medical Oncologist

Rutgers Cancer Institute of New Jersey



April 3, 2019

“Nanomedicine to Improve the Therapeutic Index of Precision Medicine,” by Daniel A. Heller, Ph.D.
Assistant Member, Memorial Sloan Kettering Cancer Center
Assistant Professor, Weill Cornell Medical College, CornellUniversity


Tuesday, March 20, 2019

Jason Berman, MD FRCPC FAAP
Attending Physician, Division of Hematology/Oncology
Associate Chair Research, Department of Pediatrics
Professor, Departments of Pediatrics, Microbiology & Immunology, and Pathology
Director, Clinician Investigator Program and Graduate Program in Medical Research Dalhousie University


February 6, 2018
“Translational Pharmacogenomics: Discovery, Education, and Implementation”
Stuart A. Scott, Ph.D., FACMG
Associate Professor, Department of Genetics and Genomic Sciences
Icahn School of Medicine at Mount Sinai
Division Head, Pharmacogenomics, Director, Cytogenetics and Cytogenomics


January 9, 2018
“MSK-IMPACT: Tumor and normal sequencing to guide diagnosis, treatment selection, and clinical trial enrollment”
Michael F. Berger, PhD
Associate Director, Marie-Josée and Henry R. Kravis Center for Molecular Oncology
Memorial Sloan Kettering Cancer Center


December 5, 2017
“Tumor Microenvironment Immune Infiltration & Clinical Utility of Targeted Sequencing for Pediatric Brain Tumors”
Prajwal Rajappa, MD
Pediatric Brain Tumor Precision Medicine Fellow
Weill Cornell Brain and Spine Center


November 17, 2017 (Special Seminar)
“Empirical Findings on the Path to Genomic Medicine
Robert C. Green, MD, MPH
Professor of Medicine (Genetics)
Director, Genomes2People Research Program
Brigham and Women’s Hospital | Broad Institute | Harvard Medical School


November 7, 2017
“Recent discoveries, therapies, and clinical implementation of rational pediatric oncology at MSKCC,” by Alex Kentsis, MD, PhD
Molecular Pharmacology Program
Experimental Therapeutics Center
Department of Pediatrics, Memorial Sloan Kettering Cancer Center


October 3, 2017
“Uveal Melanoma: Case History of a Mutant GPCR,” by Thomas Sakmar, MD
Richard M. & Isabel P. Furlaud Professor
The Rockefeller University



September 5, 2017
“Computational Pathology to Precision Medicine,” by Jeffrey A. Golden, MD
Chair, Department of Pathology
Brigham & Women’s Hospital



August 1, 2017
“Innovation through Collaboration: How an Emerging Pediatric Cancer Data Discovery Landscape is Changing the Way We Do Research,” by Adam C. Resnick, PhD
Director of the Center for Data-Driven Discovery in Biomedicine (D3b)
Director for Neurosurgical Translational Research, Division of Neurosurgery
Director of Children’s Brain Tumor Tissue Consortium in Neurosurgery (CBTTC)
The Children’s Hospital of Philadelphia


July 11, 2017
“NGS-based Comprehensive Oncogenic Virus Detection & Typing – Pilot Study Results,” by Wendy Yang, MD
Clinical Research Fellow
Department of Pathology
Memorial Sloan Kettering Cancer Center


precision cancer treatments ny


June 20, 2017
“Advanced Precision Oncology in Leukemia and Other Hematologic Malignancies,” by Duane Hassane, MD
Assistant Professor of Computational Biomedicine in Medicine
Weill Cornell Medicine


May 2, 2017
“Personalizing the Genome: The Platelet αIIbβ3 Story,” by Barry S. Coller, MD
David Rockefeller Professor of Medicine
Head, Allen and Frances Adler Laboratory of Blood and Vascular Biology
Physician-in-Chief, Rockefeller University Hospital
Vice President for Medical Affairs, Rockefeller University


January 10, 2017
“Accelerating Precision Cancer Medicine Through Clinical Computational Oncology,” by Eliezer M. Van Allen, MD
Assistant Professor of Medicine, Harvard Medical School
Department of Medical Oncology, Dana-Farber Cancer Institute
Department of Medicine, Brigham and Women’s Hospital
Associate Member, Broad Institute

December 9, 2016 (Special Seminar)
“Healthcare-integrated Biobanking / Pharmacogenomics of Fluoropyrimidines,” by Carlo Largiadèr, PhD
Vice-Director / Head of Liquid Biobank Bern
University Institute of Clinical Chemistry UKC
Inselspital, Bern University Hospital



December 6, 2016
“Clinical Implications of Long Non-coding RNAs in Solid Tumors,” by Christopher A. Maher, Ph.D.
Assistant Professor, Department of Medicine, Oncology Division, Stem Cell Biology
Department of Biomedical Engineering
Washington University Genome Institute

November 1, 2016
“Clinical impact of next-generation sequencing in pediatric oncology,” by Andrew Kung, MD, PhD
Chairman and Professor, Department of Pediatrics
Memorial Sloan-Kettering Cancer Center



October 11, 2016
“Metabolomics and Proteomics in Precision Medicine,” by Karsten Suhre, PhD
Professor of Physiology and Biophysics
Director of the Bioinformatics & Virtual Metabolomics Core
Weill Cornell Medicine-Qatar



September 13, 2016
“Algorithms for characterizing sequenced genomes and quantifying cancer evolution,” by Iman Hajirasouliha, PhD
Assistant Professor, Computational Genomics
Weill Cornell Medicine


August 9, 2016
“Emerging Themes in Cancer Biology and Their Potential Diagnostic Implications,” by Zoltan Nagy Oltvai, MD
Associate Professor, Department of Pathology
University of Pittsburgh School of Medicine


July 19, 2016
“Technology Development for Innovation in NGS-based Genomic Medicine,” by Jonathan Reichel, PhD
Lead Bioinformatics Scientist
Innovation Laboratory
Center for Molecular Oncology
Memorial Sloan Kettering Cancer Center

June 9, 2016
“From Germline and Somatic Genetics to Translational Genomics of Bladder Cancer,” by Ludmila Prokunina-Olsson, PhD
Senior Investigator, Laboratory of Translational Genomics
Division of Cancer Epidemiology and Genetics
National Cancer Institute
National Institutes of Health



March 1, 2016
“Trials and correlations: Tumor heterogeneity and clinical applications of NGS sequencing,” by Jennifer J.D. Morrissette, PhD, FACMG
Scientific Director, Clinical Cancer Cytogenetics
Department of Pathology, University of Pennsylvania


January 5, 2016
“Integration of Genomics into Clinical Care for Precision Medicine,” by Wendy Chung, MD, PhD
Associate Professor, Pediatrics in Medicine
Director, Endocrine Research Center Molecular Genetics Core
Columbia University


December 1, 2015
“Towards Precision Medicine in Neurodevelopmental Diseases,” by David Goldstein, PhD
Director, Institute for Genomic Medicine
John E. Borne Professor
Professor of Genetics and Development
Columbia University Medical Center



November 3, 2015
“Next-­gen sequencing approaches for measurement of circulating nucleic acids,” by Aghijit Patel, MD, PhD
Assistant Professor, Therapeutic Radiology
Yale University



October 6, 2015
“The Million Veteran Program – Past, Present, and Future,” by Ron Przygodzki, MD
Director, Clinical Genetic Medicine Research
U.S. Department of Veterans Affairs


June 2, 2015
“Next Generation Sequencing: Precision Cancer Diagnostics and Beyond,” by 
Marina N. Nikiforova, MD, FCAP
Professor of Pathology
Director, Molecular and Genomic Pathology Laboratory
University of Pittsburgh Medical Center


May 5, 2015
“The MSK-IMPACT Program: Prospective Clinical Cancer Genomics to Enable Personalized Oncology and Advance the Clinical Development of Targeted Therapies,” by Mark Landanyi, MD
The William Ruane Chair in Molecular Oncology
Attending Pathologist, Molecular Diagnostics Service
Member, Human Oncology and Pathogenesis Program
Memorial Sloan-Kettering Cancer Center


March 10, 2015
“Cancer Predisposition Testing in the Genomic Era,” by Colin Pritchard, MD, PhD
Assistant Professor, Medicine
Associate Director, Genetics and Solid Tumors Laboratory
University of Washington